Back
ProShares UltraShort MidCap400 Vs. Corcept Therapeutics, Inc. Industry Stock Comparison
Sell
25
MZZ
ProShares UltraShort MidCap400
Last Price:
$7.67
Seasonality Move:
-7.86%
Sell
30
CORT
Corcept Therapeutics, Inc.
Last Price:
$34.79
Seasonality Move:
13.21%
Sell
25
ProShares UltraShort MidCap400 (MZZ)
is a Sell
Is ProShares UltraShort MidCap400 a Buy, Sell or Hold?
-
The current ProShares UltraShort MidCap400 [MZZ] share price is $7.76. The Score for MZZ is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
MZZ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Corcept Therapeutics, Inc. (CORT)
is a Sell
Is Corcept Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Corcept Therapeutics, Inc. [CORT] share price is $34.80. The Score for CORT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
CORT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MZZ Stock Price Chart
What is ProShares UltraShort MidCap400's stock price today?
-
The ProShares UltraShort MidCap400 share price today is $7.76Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MZZ is experiencing buying pressure, which is a positive indicator for future bullish movement.
CORT Stock Price Chart
What is Corcept Therapeutics, Inc.'s stock price today?
-
The Corcept Therapeutics, Inc. share price today is $34.80Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing slight selling pressure.
MZZ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 43.22 | Sell |
| Chaikin Money Flow: | 144 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.88 | Sell |
| Relative Strength Index (14 RSI): | 14.83 | Sell |
| Chaikin Money Flow: | -8077532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.63 - 90.59) | Sell |
| Bollinger Bands (100): | (69.66 - 84.14) | Sell |
MZZ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.77 | Sell |
| 20-day SMA: | 7.88 | Sell |
| 50-day SMA: | 8.18 | Sell |
| 200-day SMA: | 9.2 | Sell |
| 8-day EMA: | 7.75 | Buy |
| 20-day EMA: | 7.89 | Sell |
| 50-day EMA: | 7.98 | Sell |
| 200-day EMA: | 5.4 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.24 | Sell |
| 20-day SMA: | 80.76 | Sell |
| 50-day SMA: | 77.62 | Sell |
| 200-day SMA: | 73.92 | Sell |
| 8-day EMA: | 69.79 | Sell |
| 20-day EMA: | 76.79 | Sell |
| 50-day EMA: | 77.19 | Sell |
| 200-day EMA: | 51.2 | Sell |
ProShares UltraShort MidCap400 Earnings Growth & MZZ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics, Inc. Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $3.04 per share.
ProShares UltraShort MidCap400 Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||